Colonoscopy versus biennial FIT screening: a post hoc sustained-strategy analysis of the COLONPREV Trial

Gastrointestinal Cancer

Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trial

Lancet Gastroenterol Hepatol

Schouten TJ, Prinsze KJ, Henry AC, Daamen LA, Besselink MG, Bonsing BA, Bosscha K, Busch OR, Cirkel GA, van Dam RM, van Eijck CH, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IHJT, Kazemier G, Liem MSL, de Meijer VE, Sven D Mieog J, Patijn GA, Roos D, Schreinemakers JMJ, Stommel MWJ, Wit F, van Werkhoven CH, Molenaar IQ, Smits FJ, van Santvoort HC, Dutch Pancreatic Cancer Group

doi: 10.1016/S2468-1253(25)00367-X

Inflammatory Bowel Disease

Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials

Inflamm Bowel Dis

Dubinsky MC, Schreiber S, Yarur AJ, Sands BE, Hanauer SB, Danese S, Yu H, Kim DH, Lee YN, Colombel JF

doi: 10.1093/ibd/izag017

Inflammatory Bowel Disease

Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials

Inflamm Bowel Dis

Wong ECL, Marshall JK, Ma C, Jairath V, Reinisch W, Narula N

doi: 10.1093/ibd/izag054

Inflammatory Bowel Disease

Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial

J Crohns Colitis

Raine T, Danese S, Schreiber S, Gao X, Hanauer S, Torres J, Cunneen C, Kligys K, Huang X, Garrison A, Neimark E, Anschutz T, Crowley J, Cross RK

doi: 10.1093/ecco-jcc/jjag104

Inflammatory Bowel Disease

An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 Trial

Am J Gastroenterol

Goodwin SW, Vuyyuru SK, Sedano R, Zou G, Dulai PS, Singh S, Narula N, Ma C, Jairath V

doi: 10.14309/ajg.0000000000004015

Further Publications

Fecal Hemoglobin-Guided Precision Post-polypectomy Surveillance within the Current Framework: A Four-Million-Participant FIT-based Screening Study

Gastroenterology

Pi-Chun Chuang M, Hsu WF, Su CW, Ming-Fang Yen A, Hsiu-Hsi Chen T, Hsu CY, Chiu HM

doi: 10.1053/j.gastro.2026.02.045

ColonoscopyGastrointestinal Cancer

Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trial

Lancet

Kaminski MF, Kalager M, Løberg M, Emilsson L, Macios A, Samy F, Shi J, Fielding S, Hernán MA, Garborg K, Rupinski M, Dekker E, Spaander M, Holme Ø, Zauber AG, Pilonis ND, Didkowska J, Spychalski P, Hoff G, Regula J, Adami HO, Bretthauer M, NordICC Study Group*

doi: 10.1016/S0140-6736(26)00508-8

Inflammatory Bowel Disease

Endoscopic response to subcutaneous infliximab by disease location: A post hoc analysis of the LIBERTY-CD study

Clin Gastroenterol Hepatol

Sands BE, Schreiber S, Dubinsky MC, D'Haens G, Abraham BP, Regueiro M, Danese S, Park H, Kim DH, Lee YN, Hanauer SB, Colombel JF

doi: 10.1016/j.cgh.2025.11.017

Gastrointestinal Cancer

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

Eur J Cancer

Weiss L, Stintzing S, Modest DP, Stahler A, von Weikersthal LF, Reinacher-Schick A, Decker T, Probst V, Heinrich K, Schwaner I, Kaiser F, Pihusch R, Fuchs M, Held S, Alig A, Gruenberger B, Prager GW, Tougeron D, Taieb J, Heinemann V

doi: 10.1016/j.ejca.2025.116105

Related content

Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trial

Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials

Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials

Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial

An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 Trial

Fecal Hemoglobin-Guided Precision Post-polypectomy Surveillance within the Current Framework: A Four-Million-Participant FIT-based Screening Study

Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trial

Endoscopic response to subcutaneous infliximab by disease location: A post hoc analysis of the LIBERTY-CD study

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)